Wistuba II - Search Results

1

A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.

Kadara H, Behrens C, Yuan P, Solis L, Liu D, Gu X, Minna JD, Lee JJ, Kim E, Hong WK, Wistuba II, Lotan R. Kadara H, et al. Among authors: wistuba ii. Clin Cancer Res. 2011 Mar 15;17(6):1490-501. doi: 10.1158/1078-0432.CCR-10-2703. Epub 2010 Dec 16. Clin Cancer Res. 2011. PMID: 21163870 Free PMC article.

2

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD. Fong KM, et al. Cancer Res. 1997 Jun 1;57(11):2256-67. Cancer Res. 1997. PMID: 9187130

3

Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis.

Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar J. Huang J, et al. Ann Diagn Pathol. 2001 Dec;5(6):321-9. doi: 10.1053/adpa.2001.29338. Ann Diagn Pathol. 2001. PMID: 11745069

4

Clonality of combined tumors.

Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J. Huang J, et al. Among authors: wistuba ii. Arch Pathol Lab Med. 2002 Apr;126(4):437-41. doi: 10.5858/2002-126-0437-COCT. Arch Pathol Lab Med. 2002. PMID: 11900568 Free article.

5

Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.

Toyooka S, Fukuyama Y, Wistuba II, Tockman MS, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: wistuba ii. Clin Cancer Res. 2002 Jul;8(7):2292-7. Clin Cancer Res. 2002. PMID: 12114433

6

Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma.

Wistuba II, Behrens C, Albores-Saavedra J, Delgado R, Lopez F, Gazdar AF. Wistuba II, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3615-9. Clin Cancer Res. 2003. PMID: 14506148

7

Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.

Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, Suzuki M, Miyajima K, Zhou X, Bekele BN, Gazdar AF, Wistuba II. Takahashi T, et al. Among authors: wistuba ii. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6126-33. doi: 10.1158/1078-0432.CCR-04-0579. Clin Cancer Res. 2004. PMID: 15447999

8

Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.

Tang X, Wu W, Sun SY, Wistuba II, Hong WK, Mao L. Tang X, et al. Among authors: wistuba ii. Mol Cancer Res. 2004 Dec;2(12):685-91. Mol Cancer Res. 2004. PMID: 15634757

9

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF. Shigematsu H, et al. Among authors: wistuba ii. J Natl Cancer Inst. 2005 Mar 2;97(5):339-46. doi: 10.1093/jnci/dji055. J Natl Cancer Inst. 2005. PMID: 15741570

10

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.

Shigematsu H, Takahashi T, Nomura M, Majmudar K, Suzuki M, Lee H, Wistuba II, Fong KM, Toyooka S, Shimizu N, Fujisawa T, Minna JD, Gazdar AF. Shigematsu H, et al. Among authors: wistuba ii. Cancer Res. 2005 Mar 1;65(5):1642-6. doi: 10.1158/0008-5472.CAN-04-4235. Cancer Res. 2005. PMID: 15753357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters